News

“We cannot communicate with other physicians,” says Ralph Nobo, MD and president of the Florida Medical Association. “Sometimes we cannot communicate with other entities, like labs or radiology services unless we pay a large monthly fee. That presents a challenge when you’re a small practice like I am and you’re trying to survive in these difficult times.”

Obese patients are more likely to die at home, with their weight often directly impacting their access to end-of-life care. Researchers surmise that health care professionals still harbor bias against such patients.

The investigators called over treatment “pervasive” and said it “leads to potential patient harms and excessive costs in health care.”

“Good doctoring is pattern recognition,” Tracey Evans says, “so to have all this data here and not use it is ridiculous."

Mr. DiCicco of GlaxoSmithKline speaks about an iPhone-based rheumatoid arthritis study combining patient-response surveys with the device's motion sensor capabilities.

It isn't just a fashion statement: it might also be a breakthrough.

The company is confident in the system, with CEO Jim Pearson saying he believes that “it will revolutionize the intracranial neurosurgical market."

Ultra-efficient, bright, and versatile, LEDs have changed various industries. A study recently deemed the promising new device "ready for large clinical trials."

One of the most challenging aspects of treating asthma is identifying the endotypes that underlie the condition.

Patents had protected Teva's monopoly on 40mg glatiramer acetate injections until a court ruling yesterday seemingly left the market open for generic competition.

More consumers seem comfortable with the idea of such services, and telehealth providers may have an advocate in the new administation.

With words like “crisis” and “epidemic” increasingly murmured after “opioid,” the maker of the famous, and perhaps notorious, opioid joins the effort to curb abuse.

Dan Konzen, campus chair for the College of Information Systems and Technology at the University of Phoenix speaks on four essential aspects of security to keep in mind.

With waning domestic sales hurting producers and analysts proposing a government takeover hypothetical, two new treatments have been approved in Europe.

An old standby steps back to the plate as a new entry is abandoned amidst disappointing trials, devastating its maker’s stock value.

Jim O’Neill and Balaji Srinivasan, both of whom have made controversial statements on regulation, met with President-Elect Trump last week.

Until recently, few studies had estimated the prevalence of noninfectious uveitis by inflammation location, presence of systemic conditions, sex, age, or severity.

It isn't just a TV trope. Twenty years ago, the FDA probably didn't dream it would ever have to address this sort of thing.

The IBM computer program remains a support tool for physicians and cannot replace the “human touch” needed to act upon the many factors of patient engagement.

Boston-based Berg Health is attempting to do away with a traditional form of scientific inquiry in an attempt to find better answers.

For Dr. Harrold, studies of the expansive data set underscore a need for an emphasis on the individual characteristics that make each RA case unique.

Although it is true that data streams are now quite voluminous and opportunities abound, there are plenty of caveats.

"We really do have the capability of having what everybody wants: a value-based system where the computer works for you and you don’t work for the computer."

"We have international data and interoperability standards now that define every piece of medical information...whether it’s a lab report or a PET scan report or a discharge summary."

The project, which could provide useful theory for public health response, hinges on the notion of “critical slowing down,” to determine the tipping point.

Speaking at AAO 2016, they stressed that the program is designed to supplement careful diagnosis and cut costs.

Clostridium difficile infections (C. difficile) are common, costly, and potentially fatal. But UV light can kill them.